Topsis J, Kandall S, Weinstein J, Wilets I
Division of Neonatology, Beth Israel Medical Center, New York, N.Y. 10003, USA.
J Perinatol. 1996 Mar-Apr;16(2 Pt 1):98-102.
With the use of neurologic examinations, cranial sonograms, electroencephalograms, an cry analyses, we assessed neurologic function before and after an initial diphtheria-tetanus-pertussis immunization in 22 very low birth weight infants. Mean birth weight was 1036 +/- 137 gm; mean gestational age was 28.0 +/- 1.3 weeks. All 22 infants had recovered from respiratory distress syndrome, 10 infants had been treated for invasive bacterial or fungal infection, and 9 infants had had previous intraventricular hemorrhages. Initial immunization was administered at a mean age of 71 +/- 15 days (range 57 to 120 days) and a mean weight of 1895 +/- 245 gm (1370 to 2280 gm). Clinical reactions were mild and transient. No postimmunization changes in neurologic examinations or objective studies were noted compared with results of preimmunization studies. These findings support the safety of administering an initial diphtheria-tetanus-pertussis immunization to very low birth weight infants at the recommended age of 8 weeks.
我们运用神经学检查、头颅超声检查、脑电图检查以及听力分析,对22名极低出生体重儿在初次接种白喉-破伤风-百日咳疫苗前后的神经功能进行了评估。平均出生体重为1036±137克;平均胎龄为28.0±1.3周。所有22名婴儿均已从呼吸窘迫综合征中康复,10名婴儿曾接受侵袭性细菌或真菌感染治疗,9名婴儿曾有过脑室内出血。初次接种疫苗的平均年龄为71±15天(范围57至120天),平均体重为1895±245克(1370至2280克)。临床反应轻微且短暂。与接种前研究结果相比,未发现接种后神经学检查或客观研究有变化。这些发现支持在推荐的8周龄时为极低出生体重儿接种初次白喉-破伤风-百日咳疫苗的安全性。